Millie
your market intelligence analyst
Search Results
330 results
Your search is now limited to «Partnerships and Collaborations» expert search.
PharmiWeb.com 07/19/2019 07:17
WHIPPANY, N.J. & PRINCETON, N.J. & OSAKA, Japan--(BUSINESS WIRE)--Bayer, Bristol-Myers Squibb Company(NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") announced today the three companies have entered into a clinical collaboration agreement to evaluate the combination of Bayer’s kinase inhibitor Stivarga® (regorafenib) and Bristol-Myers Squibb’s / Ono’s anti-PD-1 immune checkpoint inhibitor, Opdivo® (nivolumab) in patients with micro-satellite stable metastatic colorecta...
More from PharmiWeb.com:
Contract Pharma 07/18/2019 10:45
Aims to evaluate the combination of Bayer's Stivarga and BMS / Ono's Opdivo in patients with MSS mCRC.
More from Contract Pharma:
GlobeNewswire 07/18/2019 08:00
John Sperzel, Chembio's Chief Executive Officer, commented, "We are thrilled to collaborate with Takeda, a global pharmaceutical company, focused on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines.
More from GlobeNewswire:
PR Newswire 07/18/2019 06:32
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer.
More from PR Newswire:
World Pharma News 07/18/2019 04:00
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement.
More from World Pharma News:
Seeking Alpha 07/16/2019 17:19
Besides filing an NDA for the FDA for approval of filgotinib for RA in the United States, Gilead and its partner have plans to file for European approval to the EMA in the 2nd half of 2019 as well.
More from Seeking Alpha:
PharmTech.com 07/16/2019 13:00
GileadSciences, Inc. and Galapagos NV announced that they have entered into a 10-year global research and development collaboration, giving Gilead access to six molecules in clinical trials, more than 20 preclinical programs, a Galapagos’ drug discovery platform, and an exclusive product license and option rights to develop and commercialize current and future programs in countries ...
More from PharmTech.com:
Reuters.com 07/16/2019 11:32
(Corrects headline to "Convelo Therapeutics Enters Worldwide Collaboration with Genentech" from "Convelo Therapeutics to Acquire Genentech". Also corrects source to "Convelo Therapeutics" from "Roche Holding AG")
More from Reuters.com:
Business Wire 07/16/2019 08:30
Celgene’s progress, alongside that of Lilly, Daiichi, and Merck, which we announced earlier this year, advances our goal of enabling innovative medicines for patients around the world.
More from Business Wire:
3BL Media 07/16/2019 08:10
Merck partnered with INROADS, an international nonprofit organization that prepares talented, diverse youth for corporate and community leadership, to launch College Links in Newark, New Jersey earlier this year.
More from 3BL Media:
InPharmaTechnologist 07/16/2019 07:44
He continued, “The collaboration reflects Gilead’s intent to grow our innovation network through diverse and creative partnerships.
More from InPharmaTechnologist:
ENDPOINTS 07/16/2019 07:08
On Tuesday, the Tokyo-based company said it had joined forces with Roche’s Genentech to develop medicines that modulate G protein-coupled receptors (GPCR), an entrenched class of integral cell membrane proteins found in cells and tissues across the body.
More from ENDPOINTS:
PharmaTimes 07/15/2019 07:36
The collaboration reflects Gilead's intent to grow our innovation network through diverse and creative partnerships.
More from PharmaTimes:
Benzinga 07/14/2019 13:01
The collaboration reflects Gilead's intent to grow our innovation network through diverse and creative partnerships.
More from Benzinga:
Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH.
More from Pharmaceutical Business Review:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications